Brokerages Set HCA Healthcare, Inc. (NYSE:HCA) Target Price at $387.13

HCA Healthcare, Inc. (NYSE:HCA) has been assigned an average recommendation of “Moderate Buy” from the eighteen ratings firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation, eleven have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $387.13.

Several research analysts have recently commented on HCA shares. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their price target for the stock from $400.00 to $320.00 in a research report on Monday, November 25th. Truist Financial raised their price target on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Royal Bank of Canada increased their price objective on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Oppenheimer increased their price objective on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Finally, Morgan Stanley assumed coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective on the stock.

HCA Healthcare Trading Up 0.6 %

HCA opened at $313.93 on Wednesday. HCA Healthcare has a 52 week low of $263.22 and a 52 week high of $417.14. The business has a fifty day simple moving average of $355.34 and a 200-day simple moving average of $358.75. The firm has a market cap of $79.52 billion, a P/E ratio of 14.10, a P/E/G ratio of 1.21 and a beta of 1.63. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

Insider Transactions at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Sequoia Financial Advisors LLC boosted its holdings in HCA Healthcare by 12.5% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 2,446 shares of the company’s stock valued at $786,000 after purchasing an additional 272 shares in the last quarter. GPS Wealth Strategies Group LLC boosted its holdings in HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares in the last quarter. SteelPeak Wealth LLC purchased a new stake in HCA Healthcare in the 2nd quarter valued at approximately $1,893,000. Red Door Wealth Management LLC boosted its holdings in HCA Healthcare by 4.1% in the 2nd quarter. Red Door Wealth Management LLC now owns 20,674 shares of the company’s stock valued at $6,642,000 after purchasing an additional 806 shares in the last quarter. Finally, Westside Investment Management Inc. boosted its holdings in HCA Healthcare by 14.7% in the 2nd quarter. Westside Investment Management Inc. now owns 289 shares of the company’s stock valued at $93,000 after purchasing an additional 37 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.